Global hereditary angioedema market

Market Segmentation Global Hereditary Angioedema Market

By Drug Class    

C1 Esterase Inhibitor Kallikrein Inhibitor Bradykinin Receptor Attenuated Androgens

By Route of Administration  Subcutaneous  Intravenous  Oral

By Distribution Channels  Hospital Pharmacies  Retail Pharmacies  Online Pharmacies

By Region     

North America Europe Asia Pacific Latin America Middle East & Africa

2

Executive Summary (1/5) Table 2.1: Global Hereditary Angioedema Market Overview Parameters

2019 (E)

2029 (F)

Global Hereditary Angioedema Market Value (US$ Bn)

US$2.5Bn

XXX.X

C1 Esterase Inhibitor: XXX.X

By Drug Class Segment with Largest Value (US$ Mn)

By Drug Class Segment with Highest CAGR (%)-2019-2029

By Route of Administration Segment with Largest Value (US$ Mn)

By Route of Administration Segment with Highest CAGR (%)-2019-2029

Source: Prophecy Market Insights

XX: CAGR- XX.X

XX: XXX.X

XX: CAGR- XX.X

3

Executive Summary (2/5) Table 2.2: Global Hereditary Angioedema Market Overview Parameters By Region with Largest Value (US$ Mn) By Region with Highest CAGR (%)-2019-2029

Key Market Players:

2019 (E)

2029 (F)

North America: XXX.X

North America: CAGR- XX.X

CSL Behring, Shire Plc., Pharming Healthcare, Inc., BioCryst Pharmaceuticals, Inc., Ionis Pharmaceuticals, Inc., Arrowhead Pharmaceuticals, Adverum Biotechnologies, and Attune Pharmaceuticals, Inc.

4

Executive Summary (4/5) Description

Figure 2.1: Global Hereditary Angioedema Market Value Share (%), By Drug Class – 2019 (E)

 Hereditary angioedema is an extremely rare genetic disorder typically characterized by edema across different parts of the body. XX.X%

 Hereditary angioedema is considered to be potentially lifethreatening and can affect from 1 in 10,000 people to 1 in 50,000 people.  Increasing treatment options for hereditary angioedema, increasing of diagnosis due to advances in diagnostics is expected to boost the market.

C1 Es te ra s e I n hi bi tor Ka ll i krei n I n hi bi tor B ra d yk in in Re ce ptor Attenu ated A n drogens

Analysis  By drug class, the C1 Esterase segment is accounted for major value share 61.3% in 2019. The XYZ segment is accounted for the second highest value share XX.X% in 2019 in the target market.

5

About Us Disclaimer  The material is based on sources which we believe are reliable, but no warranty, either expressed or implied, is provided in relation to the accuracy or completeness of the information. The views expressed are our best judgment as of the date of issue and are subject to change without notice. Prophecy Market Insights takes no responsibility for decisions made on the basis of these opinions.  Any redistribution of this information is strictly prohibited. Copyright © 2019 Prophecy Market Insights pvt. Ltd , all rights reserved. Legal and Copyright Notices  While the editors endeavor to ensure the accuracy of all information and data contained in this Market Research Report, neither they nor Prophecy Market Insights Pvt. Ltd. accept responsibility for any loss or damage (whether direct or indirect) whatsoever to the customer or any third party resulting or arising there from.  All rights reserved. No part of this publication may be reproduced or used in any form or by any means graphic, electronic or mechanical, including photocopying, recording, taping, or information storage and retrieval systems without permission of the publisher. Disclaimer: Prophecy market Insights Pvt. Ltd attempts to ensure that the information provided in our market research reports is as accurate and complete as possible, the quantity of detailed information used and the fact that some of the information (which cannot always be verified or validated) is supplied by third parties and sources not controlled by prophecy market Insights Pvt. ltd means that we cannot always guarantee the accuracy, completeness or originality of the information in some reports, and we are therefore not responsible for any errors or omissions in those reports. The recipients of these reports are responsible for determining whether the information contained therein is sufficient for use and shall use their own skill and judgement when choosing to rely upon the reports Source: Prophecy Market Insights Copyright © PROPHECY 2019, All Rights Reserved

6

THANK YOU To know more about us, please visit our website:

www.prophecymarketinsights.com

For sales queries or new topics email us on:

sales@prophecymarketinsights.com For other queries contact: Alex L (Global Head - Business Development)

Prophecy Market Insights

964 E. Badillo Street #2042 Covina, CA 91724 Email: sales@prophecymarketinsights.com

Turn static files into dynamic content formats.

Create a flipbook